Full Logo No Tagline Color
Donations
Donations
Developmental Therapeutics

Developmental Therapeutics

Ongoing Studies

SAKK 66/17

Thermal laser ablation and intratumoral injection of IP-001 in patients with advanced solid tumors

SAKK 66/22

Triple-negative (hormone-independent) breast cancer, TNBC

Developmental Therapeutics Project Group

On November 22, 2019, the members of the New Anticancer Treatments Project Group and the members of the Immuno-Oncology and Molecular Oncology Working Groups decided to merge to form the new Developmental Therapeutics Project Group (PG DT). This merger allows the expertise of all members to be optimally utilized; it enables meaningful studies in the areas of immunotherapy and other therapies, potential combinations of the two areas and powerful translational programs.

The new PG DT will therefore focus more strongly on innovations in the field of oncology and have a larger number of members.